Pros and Cons of Extrapolating Animal Data on Antifungal Pharmacodynamics to Humans
{{output}}
Both the incidence of invasive fungal infections and the number of antifungal agents available to clinicians have expanded significantly over the past two decades. Successes with pharmacokinetic and pharmacodynamic evaluations of other antimicrobial agents in ... ...